Pharmacokinetics and Pharmacodynamics of Topical Decongestants Xylometazoline and Oxymetazoline: A Literature Review
Dmytro Grebeniuk, Yaroslav Hrytsun, Oleg Nikulchenko
Journal of Complementary and Alternative Medical Research · pp. 26–34 · Published 6 Nov 2023
10.9734/jocamr/2023/v24i3501Abstract
Introduction: This article provides a review and detailed analysis of scientific publications on the pharmacokinetic and pharmacodynamic characteristics of xylometazoline and oxymetazoline. Xylometazoline and oxymetazoline are two commonly used nasal decongestants used to temporarily relieve nasal congestion caused by colds, allergies, and sinusitis. Both drugs narrow blood vessels in the nasal passages, reducing edema and rhinorrhea. Aims: The aim of the study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of xylometazoline and oxymetazoline based on a literature review. Material and Methods: A retrospective review of literature data was performed using Scopus, Web of Science, PubMed, and ScienceDirect databases. Different keyword combinations, such as "topical decongestants", "xylometazoline", "oxymetazoline", "pharmacokinetics" and "pharmacodynamics", were used to search for information on the problem addressed. When processing search results, either the most recent publications (over the last 10 years) or the latest publications for this topic (regardless of their release) were chosen. Results: After reviewing abstracts and getting acquainted with their full-text articles, 47 scientific sources that met the eligibility criteria were selected. Although there are minor differences between pharmacokinetics and pharmacodynamics of xylometazoline and oxymetazoline according to available literature sources, both drugs exhibit very low systemic exposure, thus reducing the number of side effects due to the lack of systemic action and producing a high local concentration of the drugs in areas of inflammation. Besides, because of its pharmacokinetic properties, xylometazoline has a faster onset of action and a shorter duration of therapeutic effect compared to oxymetazoline.
References (40)
- 1 Subtypes of functional α1- and α2-adrenoceptors [DOI]
- 2 Presynaptic autoreceptors in the third decade: focus on α2‐adrenoceptors [DOI]
- 3 Nasal decongestants in monotherapy for the common cold [DOI]
- 4 Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections [DOI]
- 5 Abnormal Regulation of the Sympathetic Nervous System in α2A-Adrenergic Receptor Knockout Mice [DOI]
- 6 Alpha‐adrenoceptor agonistic activity of oxymetazoline and xylometazoline [DOI]
- 7 A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects [DOI]
- 8 The effect of topical xylometazoline on Eustachian tube function [DOI]
- 9 Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery – A systematic review [DOI]
- 10 Differential activity of nitric oxide synthase in human nasal mucosa and polyps [DOI]
- 11 Molecular mechanisms underlying the modulation of exocytotic noradrenaline release via presynaptic receptors [DOI]
- 12 Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours [DOI]
- 13 Rapid liquid chromatographic-mass spectrometric assay for oxymetazoline in whole rat blood [DOI]
- 14 Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging [DOI]
- 15 Effects of oxymetazoline on isolated rat’s tracheal smooth muscle [DOI]
- 16 Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management [DOI]
- 17 Measurement of nitric oxide in human nasal airway [DOI]
- 18 Control of nasal vasculature and airflow resistance in the dog. [DOI]
- 19 Selectivity of the imidazoline α‐adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned α1‐adrenoceptor subtypes [DOI]
- 20 Topically Applied Oxymetazoline [DOI]
- 21 Oxymetazoline Inhibits Proinflammatory Reactions: Effect on Arachidonic Acid-Derived Metabolites [DOI]
- 22 Contemporary decongestant practices of Canadian otolaryngologists for endoscopic sinus surgery [DOI]
- 23 Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat [DOI]
- 24 In Vitro Metabolism of Oxymetazoline: Evidence for Bioactivation to a Reactive Metabolite [DOI]
- 25 Oxymetazoline [DOI]
- 26 Adrenoceptors in the Control of Human Nasal Mucosal Blood Flow [DOI]
- 27 Interaction of the α-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors [DOI]
- 28 Pharmacological characterization of α2‐adrenoceptor‐mediated responses in pig nasal mucosa [DOI]
- 29 Improved Prediction of In Vivo Peroral Absorption from In Vitro Intestinal Permeability Using an Internal Standard to Control for Intra- and Inter-Rat Variability [DOI]
- 30 Effect of Oxymetazoline on Nasal and Sinus Mucosal Blood Flow in the Rabbit as Measured with Laser-Doppler Flowmetry [DOI]
- 31 Response of nasal blood flow to neurohormones as measured by laser-Doppler velocimetry [DOI]
- 32 Characterization of α‐adrenoceptors in the vasculature of the canine nasal mucosa [DOI]
- 33 Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. [DOI]
- 34 Evidence of 2-Adrenoceptors in the Nasal Blood Vessels of the Dog [DOI]
- 35 Sympathetic vascular control of the pig nasal mucosa: adrenoceptor mechanisms in blood flow and volume control [DOI]
- 36 Anti-oxidant actions of oxymethazoline and xylomethazoline [DOI]
- 37 Beta-adrenergic mechanisms in the nasal mucosa vascular bed [DOI]
- 38 Alpha Adrenergic Receptors: A Brief Perspective [DOI]
- 39 Effect of Oxymetazoline Nose Drops on Vascular Permeability of the Nasal Mucosa in the Rabbit after Provocation with Leukotriene B 4 [DOI]
- 40 IOSR Journal of Dental and Medical Sciences [DOI]
Cited by 4
Varee Tyagi, Vimal Katiyar · Waste and Biomass Valorization · 2025
Taner Kalayci · Brazilian Journal of Physics · 2024
Showing 2 of 4 known citations — external sources report more than can currently be individually listed.
Related research
- Anatomy: A Chronological Review of the Evolution of Context and Content — shares topic coverage
- Overview of Causes, Risk Factors and Management of Sciatica: A Review — shares topic coverage
- Optimizing the Dose-Quality Paradigm in Low-Dose CT Lung Cancer Screening: A Narrative Review — shares topic coverage
- Checklist of Phytoplankton Species in the Egyptian Waters of the Red Sea and Some Surrounding Habitats (1990-2010) — shares topic coverage
- Serotypes and Genotypes of the Hepatitis B Virus in Latin America — shares topic coverage
Article metrics
Real usage data collected on this platform.
11
Page views
0
PDF downloads
1
Outbound clicks
4
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.